Your browser doesn't support javascript.
loading
Molecular binding mode of PF-232798, a clinical anti-HIV candidate, at chemokine receptor CCR5.
Zhu, Ya; Zhao, Yan-Long; Li, Jian; Liu, Hong; Zhao, Qiang; Wu, Bei-Li; Yang, Zhen-Lin.
Afiliação
  • Zhu Y; Chinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhao YL; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Li J; Chinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Liu H; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Zhao Q; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
  • Wu BL; Chinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Yang ZL; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
Acta Pharmacol Sin ; 40(4): 563-568, 2019 Apr.
Article em En | MEDLINE | ID: mdl-29941870
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Anti-HIV / Receptores CCR5 / Compostos Azabicíclicos / Imidazóis Limite: Humans Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Anti-HIV / Receptores CCR5 / Compostos Azabicíclicos / Imidazóis Limite: Humans Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China